Exagen Inc. provided revenue guidance for the second quarter of 2023. Revenue guidance for the second quarter of 2023 in the range of $10.7 million to $11.2 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +0.71% | +1.81% | -29.15% |
26/04 | Exagen Inc. Announces Changes in Board of Directors | CI |
18/03 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.15% | 24.3M | |
+18.92% | 81.04B | |
-29.48% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-9.30% | 16.99B | |
+0.20% | 15.12B | |
+5.25% | 13.09B | |
+68.96% | 12B | |
-2.88% | 11.94B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Provides Revenue Guidance for the Second Quarter of 2023